PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)

Clinical trial NCT00536263 · COMPLETED

Trial details

NCT number: NCT00536263
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2007-09-01
Primary completion: 2009-11-01
Enrollment: 671

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.